WebWhat this means: Oncology Pharma (ONPH) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives ONPH a rank of 3. Our methodology considers analysis of the company's financial situation and how it has traded recently. ONPH rank of 3 means that it ranks below 97% of stocks. WebOncology Pharma slips on year-end operational update. Oncology Pharma (OTCPK:ONPH -7.1%) is on the decline following a year-end update on its portfolio and operations. The drug developer, which is focused on pediatrics and orphan drugs, is currently. Seekingalpha · 12/09/2024 10:40. Oncology Pharma outlines plans for next …
Oncology Pharma Inc - Company Profile and News
WebGet the latest Oncology Pharma Inc (ONPH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … WebOncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System. SAN FRANCISCO, CA / ACCESSWIRE ... graham white bell ringer
Oncology Pharma Inc. (ONPH) Latest Press Releases
WebView ONPH financial statements in full, including balance sheets and ratios. ... Oncology Pharma Inc. ONPH (U.S.: OTC) search. View All companies. AT CLOSE 3:50 PM EDT … Web13 de abr. de 2024 · Oncology Pharma saw a drop in short interest during the month of March. As of March 15th, there was short interest totaling 18,800 shares, a drop of 25.1% from the previous total of 25,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that … Web如果您是机构，请点击下方了解我们为ria、对冲基金、合规官员等提供的服务。 graham white and co